Cargando…
Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
Introduction: Current literature lacks detailed understanding of the reimbursement framework of medication adherence enhancing interventions (MAEIs). As part of the ENABLE COST Action, the EUREcA (“EUropen REimbursement strategies for interventions targeting medication Adherence”) study aimed to pro...
Autores principales: | Ágh, Tamás, Hadžiabdić, Maja Ortner, Garuoliene, Kristina, Granas, Anne Gerd, Aarnio, Emma, Menditto, Enrica, Gregório, João, Barnestein-Fonseca, Pilar, Mevsim, Vildan, Kardas, Przemysław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247400/ https://www.ncbi.nlm.nih.gov/pubmed/35784711 http://dx.doi.org/10.3389/fphar.2022.892240 |
Ejemplares similares
-
Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
por: Kardas, Przemysław, et al.
Publicado: (2022) -
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak
por: Kardas, Przemyslaw, et al.
Publicado: (2021) -
EURECA – setting the scene for scintillators
por: Kraus, H, et al.
Publicado: (2009) -
A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic
por: Ágh, Tamás, et al.
Publicado: (2021) -
Baseline Design of the Cryogenic System for EURECA
por: Burghart, Gerhard
Publicado: (2010)